Perceiv AI

As we close the chapter on #2024, many are reflecting on the past—but at Perceiv AI, we are looking forward 🚀. The next decade of drug development is set to be driven by groundbreaking neurological treatments. #Alzheimer's is now at the same inflection point that #breastcancer reached 20 years ago, following an initial wave of symptomatic drugs. We are witnessing transformative breakthroughs in #Alzheimer’s disease with disease-modifying treatments, and this momentum extends beyond AD to the entire neuro space, which is experiencing a remarkable surge in innovation and progress. At Perceiv AI, we are committed to ensuring that all trailblazers have fast and effective trials, helping bring as many therapeutic options to the table as possible.

Excited to see Perceiv AI highlighted as one of the leading companies transforming clinical trials! 🚀 A big thank you to Artefact for featuring us. By making trials faster, better, and more cost-effective, we are paving the way for the next generation of clinical research. Let’s work together to reverse EROOM's law and drive innovation forward! 💡 #AI #ClinicalTrials #Innovation

✨ Driving scientific innovation and transforming discoveries into tangible impact! The projects we fund at CQDM go beyond supporting research. They create value for companies, generate significant benefits for Quebec and Canada, and push the boundaries of scientific innovation. Discover the story of Perceiv AI, a bold Montreal-based startup leveraging artificial intelligence to predict disease progression. With our support, they successfully validated the proof of concept for their Foresight platform, reducing sample size requirements for their studies by 42%, while maintaining remarkable statistical power. ➡ Their solution has captured the attention of industry giants like Merck and Johnson & Johnson, leading to strategic partnerships and inclusion in prestigious incubators. And this is just the beginning! Today, Perceiv AI aims to revolutionize the management of complex diseases like Alzheimer’s and plans to submit an FDA approval request for one of their prognostic tools in a clinical setting. 💡Imagine what your company could achieve with a partner like CQDM. Discover the full story of Perceiv AI and many others in our collection of success stories. 📖 Read more here: https://lnkd.in/gujjAGst 👉 Could your project be our next success story? #ScientificInnovation #SuccessStories #Collaborations #QuebecSuccess CQDM DalCor Pharmaceutiques Christian Dansereau, Ph.D. Marie-Pierre Dubé Institut Cardiologie de Montréal Jean-Claude Tardif Perceiv AI

✨ Stimuler l'innovation scientifique et transformer les découvertes en impact concret ! Les projets que nous finançons au CQDM ne se limitent pas à soutenir la recherche. Ils créent de la valeur pour les entreprises, génèrent des retombées majeures pour le Québec et le Canada, et repoussent les limites de l'innovation scientifique. Découvrez l'histoire de Perceiv AI, une startup montréalaise audacieuse, qui utilise l’intelligence artificielle pour prédire l’évolution des maladies. Grâce à notre soutien, ils ont réussi à faire la preuve de concept de leur plateforme Foresight, réduisant de 42 % la taille des échantillons requis pour leurs études, tout en maintenant une puissance statistique remarquable. ➡ Leur solution a capté l’attention de géants comme Merck et Johnson & Johnson, menant à des partenariats stratégiques et leur inclusion dans des incubateurs prestigieux. Et ce n’est qu’un début ! Aujourd’hui, Perceiv AI ambitionne de révolutionner la gestion des maladies complexes comme l'Alzheimer et de soumettre prochainement une demande d’approbation auprès de la FDA pour un de ses outils pronostiques en contexte clinique. 💡 Imaginez ce que votre entreprise pourrait accomplir avec un partenaire comme le CQDM. Découvrez l’histoire complète de Perceiv AI et bien d’autres dans notre collection d’histoires à succès. 📖 À lire ici : https://lnkd.in/e2mKkDrX 👉 Et si votre projet devenait notre prochaine histoire à succès ? #InnovationScientifique #HistoireàSuccès #Collaborations #SuccèsQuébécois CQDM DalCor Pharmaceutiques Christian Dansereau, Ph.D. Marie-Pierre Dubé Institut Cardiologie de Montréal Jean-Claude Tardif Perceiv AI

🎉 Félicitations à Perceiv AI, DalCor Pharmaceuticals et au Dr Jean-Claude Tardif ! Le CQDM est fier d’annoncer que le projet de R-D collaboratif ayant permis de développer une plateforme pronostique multimodale alimentée par l’intelligence artificielle (IA) pour prédire la progression des maladies, a remporté le Prix Innovation RSRI 2024 lors du 34e Gala de l’ADRIQ, hier soir. 🏆 Ce prix célèbre l’innovation collaborative qui transforme la recherche en impact concret pour les patients. Une belle reconnaissance du travail réalisé par Perceiv AI, DalCor Pharmaceutiques et du Dr Jean-Claude Tardif. Pour en savoir plus, consultez le communiqué complet 👉 https://lnkd.in/eAtTVEeg 📸 Sur la photo : Diane Gosselin (Présidente et CEO – CQDM) Fanny Guimont-Desrochers, (Directrice des affaires scientifiques – CQDM) Mathieu Paquette, Ph.D., (Directeur Développement des Affaires et Chef d'Équipe Québec) Dubois Anick (Directrice, Initiatives Stratégiques – ICM) Christian Dansereau, (PDG - Perceiv AI) Adrián Noriega de la Colina, de la Colina (Clinical Lead - Perceiv AI) Michael Dixon (CFO - Dalcor Pharmaceutical) Ramy Hobeika, (VP finance - Dalcor Pharmaceutical) 👏 Bravo à toute l’équipe pour cette réalisation remarquable qui illustre la puissance de la collaboration en R-D ! Félicitations à tous les lauréats des Prix Innovation des RSRI, véritables acteurs de l’innovation au Québec ! 🌟 ---------------------- 🎉 Congratulations to Perceiv AI, DalCor Pharmaceuticals, and Dr. Jean-Claude Tardif! CQDM is proud to announce that the collaborative R&D project that developed an AI-powered multimodal prognostic platform to predict disease progression, has won the RSRI Innovation Award 2024 at the 34th ADRIQ Gala, last night. 🏆 This award celebrates collaborative innovation that transforms research into tangible impact for patients. It is a well-deserved recognition of the outstanding work by Perceiv AI, DalCor Pharmaceuticals, and Dr. Jean-Claude Tardif. For more details, read the full press release 👉https://lnkd.in/eFPnZu6T Congratulations to all the winners of the RSRI Innovation Awards, true drivers of innovation in Quebec! 🌟 Centre québécois de recherche et de développement de l'aluminium (CQRDA) CQDM Consortium de recherche et d'innovation en aérospatiale au Québec (CRIAQ) CRIBIQ Consortium de recherche et innovations en bioprocédés industriels au Québec DalCor Pharmaceutiques InnovÉÉ Innovation Énergie Électrique Institut Cardiologie de Montréal Fouzia Laghrissi-Thode MEDTEQ+ Perceiv AI PRIMA Québec - Pôle de recherche et d'innovation en matériaux avancés du Québec PROMPT #RSRI #ADRIQ2024 #PrixInnovation #InnovationCollaborative

It was a pleasure meeting Joaquin Duato, Chairman and CEO of Johnson & Johnson, and discussing J&J's long-term vision for #neuroscience applications. Especially following his closing comment on stage that addressing Alzheimer's and neurodegeneration is the next frontier 🧠. It is important as we move earlier in the disease course that we select the right individuals to enable successful clinical trials and true #PrecisionNeurology that provides #MeaningfulOutcomes. Neurological diseases are already the 🥇 leading cause of disability worldwide, and 1 in 3 people are expected to develop a neurological condition in their lifetime. We use prognostic insight to accelerate clinical trials and improve patient care. Perceiv AI | Forecasting disease progression | HLTH USA Adrián Noriega de la Colina

We are excited to welcome Simona Skerjanec to our board of directors. A thought leader in brain health with decades of experience in drug development and commercialization, Ms. Skerjanec has been instrumental in driving global drug development and commercialization, including leading the successful launch of Ocrevus® at Roche. Her leadership will be key as we continue to innovate in disease forecasting and advance precision neurology. We’re thrilled to have her on board as we shape the future of clinical trials and patient outcomes neurological diseases. For details see our press release: https://lnkd.in/e3aRpNuj #PrecisionMedicine #BrainHealth #AI #Innovation #ForecastingDiseaseProgression Richard Stark, César Laurent, Christian Dansereau, Ph.D.

From October 20th to 23rd, we’ll be attending HLTH Inc. in Las Vegas! ✨ Under the banner of "Healthcare Innovation from Canada" (https://lnkd.in/eKWckprD) powered by Health Technology Catalyst | CTS, Centre for Aging + Brain Health Innovation, District 3 Innovation, MaRS Discovery District, more than 30 companies, including 13 startups from Quebec, will be joining us to showcase their innovations in the Global Health Connector Village (ECHAlliance - The Global Health Connector): Join us there to hear pitches from our AI and Digital Health startups on Tuesday, October 22, from 11:15 AM to 11:35 AM: Rocket Doctor Perceiv AI Kento Health TherAppX SensifAI (https://sensifai.health/) Marble Health #HLTHUSA #AI #DigitalHealth #Pitch #GlobalConnectorVillage